Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma
- Conditions
- Refractory Multiple Myeloma
- Interventions
- First Posted Date
- 2018-11-06
- Last Posted Date
- 2023-10-12
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 82
- Registration Number
- NCT03731832
- Locations
- 🇩🇪
Kliniken Ostalb Stauferklinikum Schwäbisch Gmünd, Mutlangen, Germany
🇩🇪phase drei Hämato-Onkologischer Studienkreis am Klinikum Aschaffenburg, Aschaffenburg, Germany
🇩🇪Sozialstiftung Bamberg / Klinik am Bruderwald, Zentrum für Innere Medizin, Med. Klinik V, Hämatologie und internistische Onkologie, Bamberg, Germany
Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis
- Conditions
- Eczema, AtopicDermatitis, AtopicNeurodermatitis, Atopic
- Interventions
- Drug: Secukinumab 300 mgDrug: Placebo
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2021-05-03
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 22
- Registration Number
- NCT03568136
- Locations
- 🇩🇪
Klinische Forschung Dresden GmbH, Dresden, Germany
🇩🇪SRH Wald-Klinikum Gera, Center for Clinical Studies, Gera, Germany
🇩🇪Hannover Medical School, Department for Dermatology, Allergy and Venereology, Hannover, Germany
EXPLorative Data Collection for Patient chAracterIzation, treatmeNt Pathways and Outcomes of IRON Preparations
- Conditions
- Iron-deficiency
- First Posted Date
- 2017-12-22
- Last Posted Date
- 2019-07-02
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 51
- Registration Number
- NCT03382275
- Locations
- 🇩🇪
Praxis für Gastroenterologie, Berlin, Germany
🇩🇪Klinik für Innere Medizin I des Universiätsklinikums, Kiel, Germany
Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry
- Conditions
- Dyslipoproteinemias
- Interventions
- Drug: Standard lipid lowering therapyDrug: PCSK9 Inhibitor [EPC]
- First Posted Date
- 2017-04-12
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 1713
- Registration Number
- NCT03110432
- Locations
- 🇩🇪
Nephrologisches Zentrum, Villingen-Schwenningen, Germany
🇩🇪Klinik und Poliklinik für Kardiologie, Universitätsklinikum, Leipzig, Germany
🇩🇪Innere Medizin IV - Diabetologie, Endokrinologie und Nephrologie am Universitaetsklinikum, Tübingen, Germany
Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO)
- Conditions
- Primary ImmunodeficiencySecondary Immune Deficiency
- Interventions
- Biological: HyQvia
- First Posted Date
- 2017-02-15
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 156
- Registration Number
- NCT03054181
- Locations
- 🇩🇪
Hospital for Children and Adolescents, St. Georg Hospital, Academic Teaching Hospital, Leipzig, Germany
🇫🇷University Hospital, Paris, France
🇩🇪Charité, Berlin, Germany
Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson's Disease
- Conditions
- Parkinson's Disease
- First Posted Date
- 2017-02-06
- Last Posted Date
- 2022-07-22
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 50
- Registration Number
- NCT03043768
- Locations
- 🇩🇪
Department of Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Saxony, Germany
🇩🇪Departement of Neurology, Charite University Medicine Berlin, Berlin, Germany
🇺🇸Center for Autonomic and Peripheral Nerve Disorders, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States
Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)
- Conditions
- Metastatic Soft-tissue SarcomaAdvanced Soft-tissue Sarcoma
- Interventions
- Other: No Intervention
- First Posted Date
- 2017-01-16
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 72
- Registration Number
- NCT03022448
- Locations
- 🇩🇪
HELIOS Klinikum Bad Saarow, Bad Saarow, Germany
🇩🇪HELIOS Klinikum Berlin Buch, Berlin, Germany
🇩🇪Klinikum Spandau, Berlin, Germany
Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY
- Conditions
- Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
- Interventions
- Drug: JNJ-56022473Procedure: Bone marrow analyses and CBC with differentialOther: Flow cytometry analysesOther: Central biobankingProcedure: Histopathology analysisGenetic: Cytogenetic analysisProcedure: Serum chemistryProcedure: Automated CBCProcedure: Pregnancy Test
- First Posted Date
- 2016-12-14
- Last Posted Date
- 2018-10-25
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 25
- Registration Number
- NCT02992860
- Locations
- 🇫🇷
CHU Nantes, Nantes, France
🇫🇷Hospital Saint Louis, Paris, France
🇫🇷Hospital Archet 1, Nice, France
Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products
- Conditions
- Acne Vulgaris
- Interventions
- Drug: Acnatac® Gel left faceDrug: Acnatac® Gel right faceDrug: Epiduo® Gel left faceDrug: Epiduo® Gel right face
- First Posted Date
- 2016-04-07
- Last Posted Date
- 2018-10-23
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 22
- Registration Number
- NCT02731105
- Locations
- 🇩🇪
Universitätsklinikum Carl Gustav Carus; Klinik und Poliklinik für Dermatologie, Dresden, Saxony, Germany
INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis
- Conditions
- Superficial Vein Thrombosis
- First Posted Date
- 2016-03-04
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 1210
- Registration Number
- NCT02699151
- Locations
- 🇩🇪
Gefäßzentrum Darmstadt, Darmstadt, Germany